세계의 임신 진단 키트 시장 - 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Pregnancy Detection Kits Market was valued at USD 1.7 billion in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2034. These kits help detect pregnancy by identifying human chorionic gonadotropin (hCG) in urine or blood samples. They provide fast results without requiring medical supervision, making them a convenient option. Increasing preference for early detection tests, which identify pregnancy before a missed period, is a key growth factor. These tests offer quick confirmation, allowing timely prenatal care, better management of high-risk pregnancies, and informed decision-making. Most claim 99% accuracy, reinforcing consumer confidence.

By product, the market is divided into line pregnancy tests, digital devices, and other options. Line pregnancy tests led the market, generating USD 889.7 million in 2024. Their affordability, accessibility, and ease of use make them a top choice. These tests, available in pharmacies and online, provide instant results by detecting hCG in urine samples.

Based on test type, the market includes urine tests for hCG and blood tests for hCG. The urine test segment accounted for 63.5% of market revenue in 2024 and is anticipated to reach USD 1.8 billion by 2034. The preference for urine tests stems from their non-invasive nature, affordability, and ease of use. These tests come in strip, cassette, and midstream formats, allowing users to choose based on convenience. While strip tests require dipping in a urine sample, cassette and midstream versions eliminate this step, enhancing user experience.

By distribution channel, the market is segmented into online pharmacies, hospital pharmacies, and retail pharmacies. Hospital pharmacies generated the highest revenue of USD 917.3 million in 2024. Consumers often prefer purchasing pregnancy detection kits from hospital pharmacies due to the presence of trained medical professionals, ensuring guidance and reliability. The availability of additional hospital services, such as ultrasound imaging and blood tests, further drives demand.

Regionally, North America is a major contributor to market growth. The US pregnancy detection kits market is set to reach USD 1 billion by 2034. A high women literacy rate of 99% has increased awareness of pregnancy detection, boosting demand for home testing options. Additionally, the strong US healthcare system supports family planning initiatives and provides broad accessibility to pregnancy kits through retail and e-commerce channels, driving market expansion.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising literacy rates among women
    • 3.2.1.2 Technological advancements in rapid pregnancy diagnostics
    • 3.2.1.3 Increasing demand for at-home testing solutions
    • 3.2.1.4 Enhanced emphasis on early pregnancy detection
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Accuracy concerns in early detection
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Line pregnancy tests
• 5.3 Digital devices
• 5.4 Other products

Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Urine test for HCG
• 6.3 Blood test for HCG

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospital pharmacies
• 7.3 Online pharmacies
• 7.4 Retail pharmacies

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Cardinal Health
• 9.3 Church & Dwight
• 9.4 Danaher Corporation
• 9.5 McKesson Corporation
• 9.6 Medline Industries, LP.
• 9.7 Meridian Bioscience, Inc.
• 9.8 QuidelOrtho Corporation
• 9.9 Rapigen
• 9.10 SEKISUI CHEMICAL CO., LTD.
• 9.11 SPD Swiss Precision Diagnostics GmbH
• 9.12 Thermo Fisher Scientific